Collaboration - January 21, 2014
Medixine collaborates with Qualcomm Life
The Finnish company Medixine has announced that it is collaborating with Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, to build an integrated end-to-end solution for management and remote monitoring of chronic disease patients. According toTapio Jokinen, Medixine’s founder and chairman of the board, Qualcomm Life’s high-quality product will boost the value of Medixine’s offering […]
Collaboration - January 21, 2014
Elekta collaborates with Algeria
In efforts to treat more cancer patients, more effectively, Algeria’s Ministry of Health, Population and Hospital Reform (MoHPHR) launched an ambitious plan in 2013 to equip or build 13 new cancer centers over the next five years. The Ministry has announced that this plan includes the purchase of a variety of hardware and software solutions […]
Collaboration - January 14, 2014
Cadila Pharmaceuticals ties up with NovaSAID for drug development
Cadila Pharmaceuticals on Monday announced a partnership with Swedish NovaSAID to develop innovative treatment for inflammation and pain management. The duo will develop new treatment for inflammation and pain in conditions such as rheumatoid arthritis. NovaSAID is a company in Karolinska Development’s portfolio. The companies will collaborate around pre-clinical and clinical development of drug candidates […]
Collaboration - January 9, 2014
Elekta announces strategic partnership with McLaren Health Care
Elekta has joined forces with Michigan-based McLaren Health Care to launch MOSAIQ® oncology information system throughout McLaren’s cancer network. This partnership will enable McLaren to deploy MOSAIQ to centralize patient information across radiation oncology, particle therapy and medical oncology into a single user interface, accessible by multi-disciplinary teams across McLaren’s multiple locations. “By developing a […]
Collaboration - January 8, 2014
Immunocore, MedImmune sign oncology research collaboration and licensing agreement
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. Both companies will research and develop novel cancer therapies using Immunocore’s Immune Mobilising Monoclonal T-Cell […]
Collaboration - January 7, 2014
Horizon and AstraZeneca partner to explore oncology-relevant genotype
Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program […]
